Block of the Helix FMRFamide-gated Na+ channel by FMRFamide and its analogues

Citation
Ka. Green et Ga. Cottrell, Block of the Helix FMRFamide-gated Na+ channel by FMRFamide and its analogues, J PHYSL LON, 519(1), 1999, pp. 47-56
Citations number
18
Categorie Soggetti
Physiology
Journal title
JOURNAL OF PHYSIOLOGY-LONDON
ISSN journal
00223751 → ACNP
Volume
519
Issue
1
Year of publication
1999
Pages
47 - 56
Database
ISI
SICI code
0022-3751(19990815)519:1<47:BOTHFN>2.0.ZU;2-C
Abstract
1. In Helix neurones high doses of Phe-Met-Arg-Phe-NH2 (FMRFamide) often ev oke biphasic inward whole-cell currents with brief application, and suppres sion of the current with prolonged application. With outside-out patches, a transient early suppression of the unitary current amplitude was seen foll owing application of high doses of FMRFamide. 2. Continuous application of a concentration of FMRFamide from 30 mu M to 1 mM resulted in a reduction in the amplitude of the unitary currents and an increase in open state noise. There was also an increase in the occurrence of smaller, 'subconductance' currents with the higher concentrations of FM RFamide. Similar effects were seen with BMRFamide on FaNaC expressed in ooc ytes. The FMRFamide analogues FLRFamide and WnLRFamide were more effective in evoking the lower conductance state. These effects of agonist at high co ncentrations were voltage dependent suggesting channel block. 3. A similar effect was seen when one of the related peptides FKRFarnide, F M(D)RFamide, nLRFamide or N-AcFnLRFamide was co-applied with a low FMRFamid e concentration. However, the non-amidated peptides FKRF, FLRF and nLRF and also WMDFamide did not have this effect. 4. The inhibition of unitary currents induced by amiloride was qualitativel y different from that produced by FMRFamide analogues with no obvious occur rence of subconductance levels. FMRFamide-gated channels were also blocked by guanidinium, but only at very high concentrations. 5. The results strongly suggest a partial inhibition of current flow throug h the FMRFamide-gated channel by some part of the agonist or the related an tagonist peptide molecules.